Prognostic Utility of Anemia and Pro-B-Type Natriuretic Peptide in Patients With Nonischemic Dilated Cardiomyopathy and Normal Renal Function
- 1 February 2009
- journal article
- research article
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 337 (2) , 109-115
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failureJACC, 2004
- Anemia predicts mortality in severe heart failureJACC, 2003
- The prognostic importance of anemia in patients with heart failureThe American Journal of Medicine, 2003
- Anemia Is Common in Heart Failure and Is Associated With Poor OutcomesCirculation, 2003
- Progress in Heart Failure Management?Circulation, 2000
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000
- Plasma N-Terminal Pro–Brain Natriuretic Peptide and AdrenomedullinCirculation, 1998
- Measurement of left ventricular ejection fraction by acoustic quantification and comparison with radionuclide angiographyThe American Journal of Cardiology, 1994
- Evaluation of mitral regurgitation using a digitally determined color Doppler flow convergence 'centerline' acceleration method. Studies in an animal model with quantified mitral regurgitation.Circulation, 1994
- A new method for quantification of regurgitant flow rate using color Doppler flow imaging of the flow convergence region proximal to a discrete orifice. An in vitro study.Circulation, 1991